SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 103 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $267,000 | -18.1% | 59,747 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $326,000 | -47.8% | 59,747 | -28.4% | 0.00% | 0.0% |
| Q1 2021 | $624,000 | -35.9% | 83,447 | -7.0% | 0.00% | -50.0% |
| Q4 2020 | $974,000 | +12.5% | 89,747 | -8.4% | 0.00% | 0.0% |
| Q3 2020 | $866,000 | +51.9% | 97,947 | +83.1% | 0.00% | 0.0% |
| Q2 2020 | $570,000 | +43.9% | 53,500 | -19.8% | 0.00% | +100.0% |
| Q1 2020 | $396,000 | +10.3% | 66,700 | +28.3% | 0.00% | 0.0% |
| Q4 2019 | $359,000 | -33.5% | 52,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $540,000 | +65.6% | 52,000 | +47.7% | 0.00% | 0.0% |
| Q2 2019 | $326,000 | +3.8% | 35,200 | +2.3% | 0.00% | 0.0% |
| Q1 2019 | $314,000 | +112.2% | 34,400 | +29.3% | 0.00% | – |
| Q4 2018 | $148,000 | -51.6% | 26,600 | +3.5% | 0.00% | -100.0% |
| Q3 2018 | $306,000 | – | 25,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 4,806,656 | $58,449,000 | 19.02% |
| Casdin Capital, LLC | 182,141 | $2,215,000 | 1.83% |
| Aisling Capital LLC | 508,565 | $6,184,000 | 1.44% |
| Redmile Group, LLC | 948,440 | $11,533,000 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,812,778 | $22,043,000 | 0.91% |
| EcoR1 Capital, LLC | 63,596 | $773,000 | 0.25% |
| Eventide Asset Management | 150,000 | $1,824,000 | 0.12% |
| AWM Investment Company, Inc. | 47,550 | $578,000 | 0.11% |
| Weiss Multi-Strategy Advisers LLC | 49,000 | $596,000 | 0.03% |
| Baker Brothers Advisors | 204,465 | $2,486,000 | 0.02% |